Tokyo Tape
Sign in
← Kidswell Bio

Quarterly report · Q2

4584.TEDINET S100SALZ
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥582m2023-04-01 → 2023-09-30StandaloneNet sales
Revenue¥2.8bn2022-04-01 → 2023-03-31StandaloneNet sales (5-year summary)
Revenue¥1.1bn2022-04-01 → 2022-09-30StandaloneNet sales
Operating income−¥720m2023-04-01 → 2023-09-30StandaloneOperating income
Operating income¥11m2022-04-01 → 2022-09-30StandaloneOperating income
Ordinary income−¥745m2023-04-01 → 2023-09-30StandaloneOrdinary income
Ordinary income−¥625m2022-04-01 → 2023-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥42m2022-04-01 → 2022-09-30StandaloneOrdinary income
Profit before tax−¥780m2023-04-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax−¥42m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Net income−¥780m2023-04-01 → 2023-09-30StandaloneProfit loss
Net income−¥657m2022-04-01 → 2023-03-31StandaloneNet income loss (5-year summary)
Net income−¥43m2022-04-01 → 2022-09-30StandaloneProfit loss
Total assets¥3.2bnat 2023-09-30StandaloneAssets
Total assets¥3.9bnat 2023-03-31StandaloneAssets
Total assets¥4.3bnat 2022-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥2.1bnat 2023-09-30StandaloneLiabilities
Total liabilities¥2.7bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥1.1bnat 2023-09-30StandaloneNet assets
Net assets / equity¥1.2bnat 2023-03-31StandaloneNet assets
Net assets / equity¥1.7bnat 2022-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥622mat 2023-09-30StandaloneCash and deposits
Cash and deposits¥1.1bnat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥622mat 2023-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.9bnat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.2bnat 2022-03-31dStandaloneCash and cash equivalents
Operating cash flow−¥877m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.4bn2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥709m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥29m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥24m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥432m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.4bn2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.4bn2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-24.12023-04-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-9.292023-07-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-20.772022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1.362022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥1.222022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio27.9%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio26.6%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.2%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued35,837,613at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued32,059,713at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued31,471,147at 2022-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 386
ItemContextValueUnit
Net cash provided by used in operating activitiesCurrentYTDDuration_NonConsolidatedMember-877150000JPY
Purchase of investment securities inv cfPrior1YTDDuration_NonConsolidatedMember-50000000JPY
Purchase of investment securities inv cfCurrentYTDDuration_NonConsolidatedMember－JPY
Collection of loans receivable from subsidiaries and affiliates inv cfPrior1YTDDuration_NonConsolidatedMember26254000JPY
Collection of loans receivable from subsidiaries and affiliates inv cfCurrentYTDDuration_NonConsolidatedMember－JPY
Other net inv cfPrior1YTDDuration_NonConsolidatedMember0JPY
Other net inv cfCurrentYTDDuration_NonConsolidatedMember－JPY
Net cash provided by used in investment activitiesPrior1YTDDuration_NonConsolidatedMember-23745000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration_NonConsolidatedMember－JPY
Proceeds from long term loans payable fin cfPrior1YTDDuration_NonConsolidatedMember970000000JPY
Proceeds from long term loans payable fin cfCurrentYTDDuration_NonConsolidatedMember－JPY
Repayment of long term loans payable fin cfPrior1YTDDuration_NonConsolidatedMember-25000000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration_NonConsolidatedMember-175000000JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfPrior1YTDDuration_NonConsolidatedMember－JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYTDDuration_NonConsolidatedMember584420000JPY
Proceeds from issuance of convertible bond type bonds with subscription rights to shares fin cfPrior1YTDDuration_NonConsolidatedMember499720000JPY
Proceeds from issuance of convertible bond type bonds with subscription rights to shares fin cfCurrentYTDDuration_NonConsolidatedMember－JPY
Proceeds from issuance of subscription rights to shares fin cfPrior1YTDDuration_NonConsolidatedMember－JPY
Proceeds from issuance of subscription rights to shares fin cfCurrentYTDDuration_NonConsolidatedMember22800000JPY
Other net fin cfPrior1YTDDuration_NonConsolidatedMember1610000JPY
Other net fin cfCurrentYTDDuration_NonConsolidatedMember－JPY
Net cash provided by used in financing activitiesPrior1YTDDuration_NonConsolidatedMember1446330000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration_NonConsolidatedMember432220000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration_NonConsolidatedMember713584000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration_NonConsolidatedMember-444930000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember1160934000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1067162000JPY
Cash and cash equivalentsPrior1QuarterInstant_NonConsolidatedMember1874518000JPY
Cash and cash equivalentsCurrentQuarterInstant_NonConsolidatedMember622231000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-11-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第24期第２四半期（自　2023年７月１日　至　2023年９月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)キッズウェル・バイオ株式会社
Company name in english cover pageFilingDateInstantKidswell Bio Corporation
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　紅林　伸也
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都中央区新川一丁目２番12号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03-6222-9547（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)社長室長　栗原　隆浩
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都中央区新川一丁目２番12号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03-6222-9547（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)社長室長　栗原　隆浩
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE27032
Fund codeFilingDateInstant－
Security codeFilingDateInstant45840
Filer name in japaneseFilingDateInstant
Original text (Japanese)キッズウェル・バイオ株式会社
Filer name in englishFilingDateInstantKidswell Bio Corporation
Fund name in japaneseFilingDateInstant－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-03-31pass rounding
balance sheet identitynon_consolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass